[go: up one dir, main page]

Revision history of "CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo" (Q40246783)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 April 2024

6 May 2023

25 August 2021

24 August 2021

17 May 2021

23 December 2018

19 September 2017

18 September 2017